Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefuroxime-sulbactam vs cefoperazone-sulbactam for acute lower respiratory tract infection
CTR20131516Phase 3Completed
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cefuroxime, sulbactam in Acute bacterial lower respiratory tract infection (ABLRTI), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Jan 2014; status: completed.
02
Drugs
cefuroximesulbactam
03
Conditions
Acute bacterial lower respiratory tract infection (ABLRTI)
Beyond the preview
Go deeper on CTR20131516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131516.